Cover Image

Effect of doxycycline on stifle lameness: a preliminary clinical observation in twelve dogs

Kei Hayashi, Joseph D. Frank, Paul A. Manley, Peter Muir
  • Joseph D. Frank
    Fox Valley Animal Referral Center, United States
  • Paul A. Manley
    University of Wisconsin, United States
  • Peter Muir
    University of Wisconsin, United States

Abstract

The clinical efficacy of oral doxycycline was evaluated in twelve dogs with stifle arthritis and a presumptive diagnosis of early cruciate disease. Doxycycline (2.5-4.5 mg/kg once daily) was administered orally for 3 to 8 weeks. Eight dogs, who presented prior to the treatment with clinical signs of 4 weeks or fewer duration (group B), had a good response to doxycycline, whereas four dogs with a longer history of lameness (group A) had a poor response. The follow-up periods ranged from 2 to 12 months after discontinuation of the doxycycline treatment (median=6.5 months, 3 months in group A, and 9.5 months in group B). There was a significant correlation between the duration of lameness and the subjective grading of clinical improvement. In 68% of these cases of dogs with stifle arthritis (8/12), the oral administration of doxycycline resulted in the improvement of lameness, even after discontinuation of doxycycline. Careful selection of patients based on the duration of their lameness appears to be crucial in order to achieve a positive outcome.

Keywords

dog, arthritis, cruciate disease

Full Text:

PDF
HTML
Submitted: 2011-03-12 23:37:42
Published: 2011-07-19 10:17:41
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
1615

Views:
PDF
183
HTML
5142

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2011 Kei Hayashi, Joseph D. Frank, Paul A. Manley, Peter Muir

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185